SCHEMBL20739571

SCHEMBL20739571

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc5oc6c(-c7cccc8oc9ccccc9c78)cc(-c7cccc8oc9ccccc9c78)cc6c45)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
MAPT P10636 8/20 0.36
TSHR P16473 4/20 0.36
LMNA P02545 4/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 3/20 0.34
USP2 O75604 1/20 0.34
PLA2G2A P14555 1/20 0.34
PLA2G4A P47712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20739630 0.98 MAPT (0.38) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL20739877 0.97 PIM1 (0.37) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25459638 0.96 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25459594 0.95 ALOX5 (0.45) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL20739672 0.92 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL24928995 0.91 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL24929410 0.91 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL20739810 0.91 ALOX5 (0.47) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL22592919 0.90 ALOX5 (0.38) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL20739863 0.90 ALOX5 (0.41) ALOX5PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-31 US disclosed
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-31 US disclosed
US-20220064153-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-03-03 US disclosed
US-11208402-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2021-12-28 US disclosed
US-10818848-B2 Organic light emitting device LG CHEM, LTD. (KR) 2020-10-27 US disclosed
US-20190047991-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CRY2, PPOX ALOX5 623/4885PIM1 1125/4885CSNK2A2 2320/4885
US-11208402-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CRY2, PPOX ALOX5 623/4885PIM1 1125/4885CSNK2A2 2320/4885
US-20190047991-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, ORC3 ALOX5 749/4885PIM1 940/4885CSNK2A2 1939/4885
US-20220064153-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, ORC3 ALOX5 1141/4885PIM1 861/4885CSNK2A2 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.